Abstract:Therapeutic protein production in plants is an area of great potential for increasing and improving the production of proteins for the treatment or prevention of disease in humans and other animals. There are a number of key benefits of this technique for scientists and society, as well as regulatory challenges that need to be overcome by policymakers. Increased public understanding of the costs and benefits of therapeutic protein production in plants will be instrumental in increasing the acceptance, and thus the medical and veterinary impact, of this approach. Therapeutic recombinant proteins are a powerful tool for combating many diseases which have previously been hard to treat. The most utilized expression systems are Chinese Hamster Ovary cells and Escherichia coli, but all available expression systems have strengths and weaknesses regarding development time, cost, protein size, yield, growth conditions, posttranslational modifications and regulatory approval. The plant industry is well established and growing and harvesting crops is easy and affordable using current infrastructure. Growth conditions are generally simple: sunlight, water, and the addition of cheap, available fertilizers. There are multiple options for plant expression systems, including species, genetic constructs and protein targeting, each best suited to a particular type of therapeutic protein production. Transient expression systems provide a mechanism to rapidly transfect plants and produce therapeutic protein in a matter of weeks, rather than the months it can take for many competing expression systems, while proteins targeted to cereal seeds can be harvested, stored and potentially purified much more easily than in competing systems. Current challenges for plant expression systems include a lack of regulatory approval, environmental containment concerns and nonhuman glycosylation, which may limit the scope of the type of therapeutic proteins that can be manufactured in plants. The specific strengths of plant expression systems could facilitate the production of certain therapeutic proteins quickly and cheaply in the near future. Therapeutic protein production in plants is an area of great potential for increasing and improving the production of proteins for the treatment or prevention of disease in humans and other animals. There are a number of key benefits of this technique for scientists and society, as well as regulatory challenges that need to be overcome by policymakers. Increased public understanding of the costs and benefits of therapeutic protein production in plants will be instrumental in increasing the acceptance, and thus the medical and veterinary impact, of this approach.

Single-Step Purification and Characterization of A Recombinant Serine Proteinase Inhibitor from Transgenic Plants

Heterologous Expression, Refolding, and Characterization of a Calcium-Independent Phospholipase A1 from Streptomyces Albidoflavus

An in-built proteinase inhibitor system for the protection of recombinant proteins recovered from transgenic plants

Expression and Purification of Recombinant Human Serum Albumin from Selectively Terminable Transgenic Rice

Removal of plant endogenous proteins from tobacco leaf extract by freeze-thaw treatment for purification of recombinant proteins

Transgenic tobacco plants as production platform for biologically active human interleukin 2 and its fusion with proteinase inhibitors

High level expression and biochemical characterization of an alkaline serine protease from Geobacillus stearothermophilus to prepare antihypertensive whey protein hydrolysate

Optimization and characterization of tomato seed protein isolate: a sustainable source of functional protein

Production, purification, and characterization of human α1 proteinase inhibitor from Aspergillus niger

Bioprospecting of serratiopeptidase-producing bacteria from different sources

Cost‐effective production of tag‐less recombinant protein in Nicotiana benthamiana

Expression of Recombinant Aprotinin in E.coli and the Identification of Its Biological Activity

Optimising expression and extraction of recombinant proteins in plants

Progress Of Transgenic Plant As Bioreactor For Pharmaceutical Proteins

Heterologous Production of Cyprosin B in : Unveiling the Role of the Plant-Specific Insert Domain in Protein Function and Subcellular Localization

Membrane-based inverse-transition purification facilitates a rapid isolation of various spider-silk elastin-like polypeptide fusion proteins from extracts of transgenic tobacco

Purification of therapeutic proteins mediated by in vivo polyester immobilized sortase

In vivo polyester immobilized sortase for tagless protein purification

Green biofactories: recombinant protein production in plants

Therapeutic recombinant protein production in plants: Challenges and opportunities

Expression,Production Purification and Identification of Recombinant Human Plasminogen Gene in Yeast